Lesley Calhoun
Fortune : 167 106 $ au 31/05/2026
Fortune : 167 106 $ au 31/05/2026
Lesley Ann Calhoun is currently Director at Tango Therapeutics Sub, Inc. since 2021, Independent Director at Tango Therapeutics, Inc. since 2021, Treasurer at California Life Sciences Association, and Executive VP, Chief Operating & Financial Officer at Aligos Therapeutics, Inc. since 2020.
Former roles include Senior Director-Finance & Controller at Innoviva, Inc. from 2005 to 2013, Vice President-Finance at Hyperion Therapeutics, Inc. from 2013 to 2015, Chief Accounting Officer & SVP-Administration at Global Blood Therapeutics, Inc. from 2016 to 2020, and Member at Deloitte & Touche LLP from 1989 to 2001.
Education includes undergraduate studies at San Francisco State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 6 250 ( 0 % ) | 137 375 $ | 31/05/2026 | |
| 31/03/2026 | 5 216 ( 0,1 % ) | 29 731 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Directeur Financier/CFO | 01/06/2020 |
| TANGO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2021 |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Directeur/Membre du Conseil | 24/03/2021 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Directeur Administratif | 01/06/2020 |
| HYPERION THERAPEUTICS INC | Corporate Officer/Principal | 01/09/2015 |
| INNOVIVA, INC. | Directeur Financier/CFO | 01/01/2013 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 01/01/2001 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Hyperion Therapeutics, Inc.
Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Innoviva, Inc.
Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national